Seventure Partners
Seventure Partners is a European venture capital firm founded in 1997 and based in Paris, with €1 billion under management as of June 2024. It actively funds innovative companies in the fields of Digital technologies and Life sciences, supporting their growth and contributing to economic development in Europe.
Seventure Partners is a Paris venture capital firm with €704M AUM, 126 active companies and 10 exits.
- ·7 exits in the last 5 years · consistent DPI cadence.
- ·Average hold across 7 realized deals: 6 years.
- ·Top sector focus: Biotech (31% of portfolio).
- ·Fund cadence: ~2Y between vintages · last raise 2022.
Sector breakdown
134 companiesGeography breakdown
17 geographiesKey facts
Recent exits
Seventure Partners sold 365Talents to Docebo in 2026 after 7 years.
Seventure Partners sold Saagie to Scaleway in 2025 after 5 years.
Seventure Partners sold Wealthpilot to Finaplus in 2025 after 5 years.
Seventure Partners exited DayTwo in 2024 after 7 years.
Coverage notes
9 funds tracked, 136 portfolio companies (126 active · 10 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Seventure Partners has raised, with its portfolio companies. Hand-checked from public filings.
Blue Forward FundGrowth2022€130M11 assetsGrowth2022 · 4yr€130M11–
Unrealized
11 held| Company | Entry |
|---|---|
| Chemdoc ClimateTech · France | 2023 |
| Dielen Laboratoire ClimateTech · France | 2020 |
| Eauzons! ClimateTech · France | 2023 |
| FreeJump System Consumer · France | 2022 |
| GIT Energy · Canada | 2022 |
| GOA Ventures ClimateTech · Netherlands | 2022 |
| Inalve ClimateTech · France | 2022 |
| Seaweed Concept ClimateTech · France | 2023 |
| Sinay ClimateTech · France | 2022 |
| Syroco ClimateTech · France | 2025 |
| vorteX-io ClimateTech · France | 2026 |
Digital Opportunities Fund IIVC2020€80M9 assets1 exitsVC2020 · 6yr€80M91
Unrealized
9 heldRealized
1 exit| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Saagie Data & Analytics · France | 2020 | 2025 | Trade Sale | Scaleway | – |
Health for Life Capital IIVC2020€200M6 assetsVC2020 · 6yr€200M6–
Unrealized
6 held| Company | Entry |
|---|---|
| Nanobiotix Biotech · France | 2023 |
| RevivBio Biotech · US | 2023 |
| String BIO Biotech · Inde | 2023 |
| Tibot Healthcare · France | 2020 |
| Tubulis Biotech · Germany | 2021 |
| Virovet Biotech · Belgium | 2023 |
Sport & Performance CapitalVC2019€80M17 assetsVC2019 · 7yr€80M17–
Unrealized
17 held| Company | Entry |
|---|---|
| Anybuddy Hospitality · France | 2025 |
| Baouw Consumer · France | 2023 |
| bsport Consumer · France | 2023 |
| Clim8 Consumer · France | 2020 |
| Ekstere Consumer · France | 2025 |
| Exo Consumer · France | 2024 |
| Freejump Consumer · France | 2022 |
| Geovelo Consumer · France | 2022 |
| Hardloop E-commerce · France | 2019 |
| Karius Biotech · US | 2020 |
| Karmen Fintech · France | 2022 |
| Kinomap Consumer · France | 2019 |
| Move’n See Consumer · France | 2019 |
| Skillcorner Consumer · France | 2020 |
| SportEasy Consumer · France | 2019 |
| The Sancturary Group Consumer · France | 2022 |
| Zenniz Consumer · Finlande | 2026 |
AVF FundVC2018€24M1 assetsVC2018 · 8yr€24M1–
Unrealized
1 held| Company | Entry |
|---|---|
| Animab Biotech · Belgium | 2020 |
Digital Opportunities FundVC2017€56M20 assets3 exitsVC2017 · 9yr€56M203
Unrealized
20 held| Company | Entry |
|---|---|
| Aston Itrade Finance Fintech · France | 2020 |
| Flexvelop Fintech · Germany | 2020 |
| Hackuity Business Services · France | 2022 |
| Hepster InsurTech · Germany | 2020 |
| Homerez PropTech · France | 2013 |
| Ideel Fintech · France | 2022 |
| Inspecto Healthcare · Israel | 2022 |
| Izicap Fintech · France | 2020 |
| Jobteaser HR Tech · France | 2018 |
| Jolimoi E-commerce · France | 2019 |
| Launchmetrics Software | – |
| Own Security Cybersecurity · France | 2022 |
| Rejolt (ex Business... Fintech · France | 2021 |
| Secure-IC Cybersecurity · France | 2020 |
| Sekoia.io Cybersecurity · France | 2021 |
| Sentryc E-commerce · Germany | 2021 |
| Siit SaaS · France | 2022 |
| Sumup Fintech · Germany | 2019 |
| TransferGo Fintech · UK | 2019 |
| YesWeHack Cybersecurity · France | 2021 |
Realized
3 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| 365Talents HR Tech · France | 2019 | 2026 | Trade Sale | Docebo | – |
| Medius (Expensya) Fintech · France | 2018 | 2023 | Trade Sale | Medius Sverige AB | – |
| Wealthpilot Fintech · Germany | 2020 | 2025 | Trade Sale | Finaplus | – |
Health for Life CapitalVC2014€160M53 assets3 exitsVC2014 · 12yr€160M533
Unrealized
53 held| Company | Entry |
|---|---|
| Abalos Biotech · Germany | 2021 |
| Allozymes Biotech · France | 2022 |
| Anaeropharma Biotech · Japan | 2021 |
| BiomX Biotech · Israel | 2017 |
| CardioSecur MedTech · Germany | 2019 |
| CattleEye AgTech · Ireland | 2021 |
| Citryll Biotech · Netherlands | 2021 |
| Clinical Microbiomics | – |
| Cmbio –... Biotech · Denmark | 2023 |
| Corpowell (Vecollal) Biotech · Belgium | 2021 |
| CorWave MedTech · France | 2019 |
| Cytoki Biotech · Denmark | 2023 |
| Dermala Biotech · US | 2020 |
| Dopavision MedTech · Germany | 2020 |
| Ecto Healthcare · US | 2021 |
| Eligo Biotech · France | 2019 |
| Enterome Biotech · France | 2016 |
| Ervimmune Biotech · France | 2022 |
| Federation Bio Biotech · US | 2022 |
| Foodsmart Biotech · US | 2021 |
| Impeto Medical MedTech · France | 2016 |
| Kainova Therapeutics Biotech · Canada | 2026 |
| Kapsera Healthcare · France | 2023 |
| Kebony Construction · Norway | 2022 |
| La Vie FoodTech · France | 2022 |
| Larq Biotech · US | 2020 |
| Lecturio Software · Germany | 2020 |
| MaaT Pharma Biotech · France | 2026 |
| Machtfit Biotech · Germany | 2018 |
| Mainstay MedTech · Ireland | 2022 |
| Mauna Kea MedTech · France | 2015 |
| MedEye MedTech · Netherlands | 2019 |
| MedinCell Pharma · France | 2017 |
| Microbiotica Biotech · UK | 2026 |
| Myco Technology Biotech · US | 2020 |
| Nexess Telecom · France | 2016 |
| Nimble Sciences Biotech · Canada | 2023 |
| Novobind Biotech · Canada | 2022 |
| One Bio ex BCD... Biotech · US | 2022 |
| Peptobiotics Biotech · Singapore | 2023 |
| Proteon... Biotech · Poland | 2022 |
| Protip MedTech · France | 2016 |
| Quanta MedTech · UK | 2023 |
| Sequentia FoodTech · Spain | 2023 |
| Siolta Therapeutics Biotech · US | 2020 |
| Standing Ovation Biotech · France | 2026 |
| Starfish Biotech · France | 2023 |
| Sunrise MedTech · Belgium | 2024 |
| Targedys Biotech · France | 2019 |
| Testbirds Business Services · Germany | 2018 |
| The Akkermansia... Biotech · Belgium | 2020 |
| Vedanta Biotech · US | 2020 |
| Vertero... Biotech · US | 2023 |
Quadrivium 1 Seed FundVC2013€56M8 assets1 exitsVC2013 · 13yr€56M81
Unrealized
8 heldRealized
1 exit| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Biomatlante MedTech · France | 2016 | 2019 | Trade Sale | Advanced Medical Solutions | – |
Spef Pre-IPOVC2007€30M1 assetsVC2007 · 19yr€30M1–
Unrealized
1 held| Company | Entry |
|---|---|
| Endocontrol MedTech · France | 2017 |
Other portfolio companies
2 more Seventure Partners investments not tied to a tracked fund.
- PrestaShop · E-commerce · France · exited 2021
- Sentryo · Cybersecurity · France · exited 2019
About Seventure Partners
Seventure Partners is a European venture capital firm with €1 billion of assets under management as of June 2024, founded in 1997 and headquartered in Paris. The firm specialises in Digital and Life Sciences themes with global recognition as a leading microbiome-focused investor through dedicated themed funds. Seventure operates as part of Natixis Investment Managers within the broader Groupe BPCE financial group.
Investment thesis
Seventure deploys venture capital across two complementary themes: Digital (enterprise software, fintech, digital media) and Life Sciences (biotech, MedTech, HealthTech with particular depth in microbiome and nutrition themes). Investment stages span early-stage seed and Series A through growth equity commitments. The microbiome thematic franchise distinguishes Seventure as one of the few European VCs with dedicated capital for that emerging scientific vertical, with equity tickets typically ranging from €1 million to €15 million per transaction.
Recent activity
Recent realised exits include 365Talents (business services, 2026), Saagie (business services, 2025), Medius Expensya (fintech, 2023) and Polaris (biotech, 2023), reflecting active distribution across the technology and life sciences franchises. The platform tracks 10 funds and 126 active portfolio companies across the multi-decade European VC programme.
Frequently asked questions
- What investment strategy does Seventure Partners focus on?
- Seventure Partners focuses on VC, Growth strategies in the private equity space.
- How many portfolio companies does Seventure Partners have?
- Seventure Partners has 126 active portfolio companies and 10 completed exits and 9 funds tracked on GP Intel.
- Where is Seventure Partners headquartered?
- Seventure Partners is headquartered in Paris, France.
- What is Seventure Partners's assets under management?
- Seventure Partners manages approximately €704M in assets under management.
- When was Seventure Partners founded?
- Seventure Partners was founded in 1983.
- What sectors does Seventure Partners invest in?
- Seventure Partners invests across Healthcare, Software, Consumer, Business Services.
- What are Seventure Partners's recent exits?
- Recent realized exits by Seventure Partners include: 365Talents (2026) to Docebo; Saagie (2025) to Scaleway; Wealthpilot (2025) to Finaplus; Pixium (2024) to Science Corporation; Medius (Expensya) (2023) to Medius Sverige AB; Polaris (2023) to Cerea Partners; Biomatlante (2019) to Advanced Medical Solutions.
Similar firms
Other private equity firms tracked on GP Intel.